Outset Medical vs Neuronetics
Neuronetics reported revenue of $149 million in fiscal 2025, 1.2 times Outset Medical's $120 million in fiscal 2025. Outset Medical's revenue grew 5.1% in its latest year, and Neuronetics' grew 99.2%. Outset Medical had an operating margin of -55.8%, against -21.1% at Neuronetics. Free cash flow was −$47 million at Outset Medical and −$21 million at Neuronetics.
Side by side
| Outset Medical | Neuronetics | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $120M | $149M |
| Revenue growth | 5.1% | 99.2% |
| Revenue growth a year, last 5 years | 19.1% | 24.8% |
| Gross margin | 39.1% | 48.5% |
| Operating margin | −55.8% | −21.1% |
| Net margin | −68.3% | −26.1% |
| Free cash flow | −$47M | −$21M |
| Free cash flow margin | −39.4% | −14.2% |
| Return on capital | −88.0% | −37.5% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 339.2% | 107.8% |
| Last close | $2.91 | $1.24 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | sold $362,051 | bought $4.8 million, sold $270,405 |
| Piotroski F-score | 6 of 9 | 4 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Outset MedicalNeuronetics
Operating margin
Percent of revenue
Outset MedicalNeuronetics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Outset MedicalNeuronetics
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Outset Medical and Neuronetics pages.